Recently, elevated cathepsin L activity has been reported in murine models with pancreatic cancer, with reduction in the tumour size after its gene deletion.13 Cathepsin L inhibition by covalent inhibitors was shown to suppress proliferation of pancreatic cancer cells,11 and colorectal adenocarcinoma cells.14 Here, CTSL is linked to colorectal adenocarcinoma.